Associated Papers
PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer.
Wang Y et al.
Military Medical Research, 2026
41491583 (PubMed )
Supplement: 40779_2025_679_MOESM1_ESM.xlsx › Table_S8
Structural Adaptability of IgA and IgM Supports Broad SARS-CoV-2 Variant Neutralization.
Pisil Y et al.
Journal of Medical Virology, 2026
An Italian Single-Center Genomic Surveillance Study: Two-Year Analysis of SARS-CoV-2 Spike Protein Mutations.
Cecchetto R et al.
International Journal of Molecular Sciences, 2025
Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants.
Lusvarghi S et al.
Plos Pathogens, 2023
Omicron variant evolution on vaccines and monoclonal antibodies.
Sabbatucci M et al.
Inflammopharmacology, 2023
Multiplex RT Real-Time PCR Based on Target Failure to Detect and Identify Different Variants of SARS-CoV-2: A Feasible Method That Can Be Applied in Clinical Laboratories.
Pham VH et al.
Diagnostics (basel, Switzerland), 2023
Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities.
Alam MS
Heliyon, 2023
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies.
Chatterjee S et al.
Viruses, 2023
Genomic surveillance of genes encoding the SARS-CoV-2 spike protein to monitor for emerging variants on Jeju Island, Republic of Korea.
Ha YR et al.
Frontiers in Microbiology, 2023
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far.
Chavda VP et al.
Vaccines, 2022
Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2.
Pastorio C et al.
Cell Host & Microbe, 2022
35931073 (PubMed )
Supplement: mmc3.pdf
Most frequently harboured missense variants of hACE2 across different populations exhibit varying patterns of binding interaction with spike glycoproteins of emerging SARS-CoV-2 of different lineages.
Tahsin A et al.
Computers in Biology and Medicine, 2022
Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in "Mini-gut" Organoids.
Miyakawa K et al.
Gastroenterology, 2022
35500619 (PubMed )
Supplement: mmc1.pdf
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.
Willett BJ et al.
Nature Microbiology, 2022
Omicron variant losing its critical mutations in the receptor-binding domain.
Desingu PA et al.
Journal of Medical Virology, 2022
Is Omicron the end of pandemic or start of a new innings?
Das S et al.
Travel Medicine and Infectious Disease, 0
Select a paper to view details